DorsaVi Limited Reports Substantial Revenue Decline

dorsaVi Limited (AU:DVL) has released an update.

DorsaVi Limited reported a significant downturn in its financial performance for the fiscal year ending June 30, 2024, with revenues decreasing by 35% to $1,335,041 and losses after tax reducing by 31.5% to $1,247,582. The company experienced a notable decline across its clinical and workplace income streams, with no dividends paid to shareholders during the period. Expenditure saw a 31% reduction, primarily due to lower employee benefits expenses.

For further insights into AU:DVL stock, check out TipRanks’ Stock Analysis page.